ResearcherVeterans Health AdministrationActive in the last 2 years
Theresa Wicklin Gillespie
Matched on ORCID iD 0000-0001-8734-716X; OpenAlex author ID A5056296628, A5126203923. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2013: 2 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 7
- Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma. Last author DOI 10.1245/s10434-026-19132-z↗
- ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic Adenocarcinoma. Last author DOI 10.1245/s10434-026-19311-y↗
- Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radia… Co-author DOI 10.1002/cncr.30706↗
- Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. Co-author DOI 10.1002/cncr.28530↗
- The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2013.06.803↗
- The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.28047↗
- Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. First author DOI 10.1245/s10434-013-3047-x↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David A. Kooby · 7 shared papers, 2013–2026 · strength 0.83
- Paper Optimal Timing of Adjuvant Therapy in Patients with Poorly Differentiated Pancreatic Adenocarcinoma. DOI 10.1245/s10434-026-19132-z↗
- Paper ASO Visual Abstract: Optimal Timing of Adjuvant Therapy for Patients with Poorly Differentiated Pancreatic Adenocarcino… DOI 10.1245/s10434-026-19311-y↗
- Paper Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy … DOI 10.1002/cncr.30706↗
- Juan Manuel Sarmiento · 2 shared papers, 2026 · strength 0.60
- Parit T. Mavani · 2 shared papers, 2026 · strength 0.60
- Mihir Maheshkumar Shah · 2 shared papers, 2026 · strength 0.60
- Jerome Carl Landry · 5 shared papers, 2013–2017 · strength 0.23
- Paper Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy … DOI 10.1002/cncr.30706↗
- Paper Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. DOI 10.1002/cncr.28530↗
- Paper The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2013.06.803↗
- William Adrian Hall · 4 shared papers, 2013–2017 · strength 0.19
- Paper Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy … DOI 10.1002/cncr.30706↗
- Paper Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. DOI 10.1002/cncr.28530↗
- Paper The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2013.06.803↗
- Joseph Lipscomb · 4 shared papers, 2013–2014 · strength 0.16
- Paper Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. DOI 10.1002/cncr.28530↗
- Paper The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2013.06.803↗
- Paper Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national c… DOI 10.1245/s10434-013-3047-x↗
- Lauren Elizabeth Colbert · 3 shared papers, 2013–2014 · strength 0.12
- Paper Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. DOI 10.1002/cncr.28530↗
- Paper The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma. DOI 10.1016/j.ijrobp.2013.06.803↗
- Paper The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. DOI 10.1002/cncr.28047↗
- Pretesh R Patel · 1 shared paper, 2017 · strength 0.07
- Jim Zhong · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.